FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
What is the latest Total Liabilities ratio of FREDUN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹308 Cr |
Mar2023 | ₹257 Cr |
Mar2022 | ₹187 Cr |
Mar2021 | ₹162 Cr |
Mar2020 | ₹141 Cr |
How is Total Liabilities of FREDUN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹308 Cr | 19.56 | |
Mar2023 | ₹257 Cr | 37.59 | |
Mar2022 | ₹187 Cr | 15.70 | |
Mar2021 | ₹162 Cr | 14.32 | |
Mar2020 | ₹141 Cr | - |
Compare Total Liabilities of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹334.8 Cr | -3.4% | -3% | -14.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 3.7% | 8.5% | 49.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 3.6% | 1.8% | 52.1% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 3% | 1.9% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 2.7% | 15.5% | 23.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -1.6% | 1% | 43.9% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | -3.4% |
-3% |
-14.9% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses